These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37316681)

  • 21. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models.
    McCampbell A; Cole T; Wegener AJ; Tomassy GS; Setnicka A; Farley BJ; Schoch KM; Hoye ML; Shabsovich M; Sun L; Luo Y; Zhang M; Comfort N; Wang B; Amacker J; Thankamony S; Salzman DW; Cudkowicz M; Graham DL; Bennett CF; Kordasiewicz HB; Swayze EE; Miller TM
    J Clin Invest; 2018 Aug; 128(8):3558-3567. PubMed ID: 30010620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation.
    Masrori P; Ospitalieri S; Forsberg K; Moens TG; Poesen K; Race V; Brännström T; Andersen PM; Thal DR; Van Damme P
    Eur J Neurol; 2022 Apr; 29(4):1279-1283. PubMed ID: 35253968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New mutation in the SOD1 (copper/zinc superoxide dismutase-1) gene in a Chinese amyotrophic lateral sclerosis (ALS) patient.
    Cui F; Cai W; Wang Z; Ren Y; Li M; Sun Z; Huang X
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):635-7. PubMed ID: 23889606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facial onset amyotrophic lateral sclerosis with K3E variant in the Cu/Zn superoxide dismutase gene.
    Shibuya K; Sawai S; Sugiyama A; Koide M; Nishiyama A; Aoki M; Kuwabara S
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb; 22(1-2):144-146. PubMed ID: 32729725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing Clinical Infrastructure for the Delivery of Intrathecal and Genetic Therapies: A Qalsody (Tofersen) Model for Patients With
    Morganroth J; Bardakjian TM; Dratch L; Quinn CC; Elman LB
    Neurol Clin Pract; 2024 Aug; 14(4):e200303. PubMed ID: 38855716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutations.
    Coppedè F; Stoccoro A; Mosca L; Gallo R; Tarlarini C; Lunetta C; Marocchi A; Migliore L; Penco S
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):93-101. PubMed ID: 28859526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Identification of the mutation of SOD1 gene in a familial amyotrophic lateral sclerosis].
    Shi SG; Li LS; Chen KN; Liu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):149-52. PubMed ID: 15079798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis.
    Sangwan S; Eisenberg DS
    Postepy Biochem; 2016; 62(3):362-369. PubMed ID: 28132491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promise of Nucleic Acid Therapeutics for Amyotrophic Lateral Sclerosis.
    Ito D
    Ann Neurol; 2022 Jan; 91(1):13-20. PubMed ID: 34704267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tofersen: Silver Lining or Hyperbole??
    Chawla T; Goyal V
    Ann Indian Acad Neurol; 2023; 26(5):638-640. PubMed ID: 38022476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
    Hayashi Y; Homma K; Ichijo H
    Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of diabetes in a familial amyotrophic lateral sclerosis patient carrying the I113T SOD1 mutation. Case Report.
    Hamasaki H; Takeuchi Y; Masui Y; Ohta Y; Abe K; Yoshino H; Yanai H
    Neuro Endocrinol Lett; 2015; 36(5):414-6. PubMed ID: 26707039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of amyotrophic lateral sclerosis.
    Robberecht W
    J Neurol; 2000 Dec; 247 Suppl 6():VI/2-6. PubMed ID: 19714405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slow progression of amyotrophic lateral sclerosis in a Chinese patient carrying SOD1 p.S135T mutation.
    Fu H; Zhang K; Yang X; Li L; Cui L
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Feb; 23(1-2):143-145. PubMed ID: 33860706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNase-H-mediated silencing in the CNS proves predictably nontrivial.
    Moazami MP; Wood MJA
    Med; 2022 Nov; 3(11):733-734. PubMed ID: 36370693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations.
    Orrell RW
    Neuromuscul Disord; 2000 Jan; 10(1):63-8. PubMed ID: 10677867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel T137A SOD1 mutation in an Italian family with two subjects affected by amyotrophic lateral sclerosis.
    Visani M; de Biase D; Bartolomei I; Plasmati R; Morandi L; Cenacchi G; Salvi F; Pession A
    Amyotroph Lateral Scler; 2011 Sep; 12(5):385-8. PubMed ID: 21574856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?
    Shaw BF; Valentine JS
    Trends Biochem Sci; 2007 Feb; 32(2):78-85. PubMed ID: 17208444
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.